Active drug: pimavanserin 17mg (2 strength tablets)
6398
Phase 2 small_molecule completed
Quick answer
Active drug: pimavanserin 17mg (2 strength tablets) for Parkinson Disease is a Phase 2 program (small_molecule) at Acadia Pharmaceuticals B.V. with 1 ClinicalTrials.gov record(s).
Program details
- Company
- Acadia Pharmaceuticals B.V.
- Indication
- Parkinson Disease
- Phase
- Phase 2
- Modality
- small_molecule
- Status
- completed